Page results
-
This information has been written for patients who are having radiotherapy treatment to the brain and spine.
-
This page is for parents and carers of children with sickle cell disease. It explains what happens during a Transcranial Doppler Scan.
-
This page is about the leukaemia multidisciplinary team (MDT) and how they can help you through your treatment.
-
Information about sickle cell disorder in adulthood for UCLH patients.
-
This information is about penile cancer multidisciplinary team (MDT), the a team of professionals who will be caring for you at University College Hospital (UCLH).
-
Information about community sickle cell and thalassaemia services provided via UCLH.
-
This information page aims to answer some of the questions you may have about receiving chimeric antigen receptor (CAR) T-cell therapy at University College London Hospitals NHS Foundation Trust (UCLH).
-
This information explains what alpha thalassaemia is, and provides information about the different types of alpha thalassaemia.
-
This page explains what autologous stem cell transplant is and includes information about our stem cell transplant service and process, the care patients will receive and what to expect after the transplant.
-
Being diagnosed with cancer can be a difficult time for you and those close to you. This page gives you an overview of the care you can expect to receive as our patient at University College London Hospitals NHS Foundation Trust (UCLH). It also introduces different types of healthcare professionals you may meet along the way.
File results
-
FOI/2021/0658 - Food waste at the Trust
-
FOI/2021/0686 - IT security strategy
-
FOI/2021/0692 - Delayed patient discharge
-
FOI/2021/0694 - Eletronic Health Records - patient data
-
FOI/2021/0696 - Procurement of Robotic Process Automation (RPA)
-
FOI/2021/0704 - Language translation and interpreting services
-
FOI/2021/0708 - Treatment of dermatological conditions
-
FOI/2021/0713 - Incidence and treatment of Haemophilia A
-
FOI/2021/0714 - Data management systems of care testing devices
-
FOI/2021/0715 - Urothelial cancer treatment